Euglycemic diabetic ketoacidosis in association with dapagliflozin use after gastric sleeve surgery in a patient with type II diabetes mellitus

Sodium–glucose cotransporter 2 inhibitors (SGLT2Is) can be associated with euglycemic diabetic ketoacidosis (eDKA). Severe metabolic acidosis with extreme electrolyte abnormalities can occur with nonsignificant blood glucose elevations in SGLT2I‐treated patients. Additional risk factors for eDKA inc...

Descripción completa

Detalles Bibliográficos
Autores principales: Banakh, Iouri, Kung, Ross, Gupta, Sachin, Matthiesson, Kati, Tiruvoipati, Ravindranath
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2019
Materias:
Case Reports
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6509932/
https://www.ncbi.nlm.nih.gov/pubmed/31110751
http://dx.doi.org/10.1002/ccr3.2147
_version_ 1783417348174118912
author Banakh, Iouri
Kung, Ross
Gupta, Sachin
Matthiesson, Kati
Tiruvoipati, Ravindranath
author_facet Banakh, Iouri
Kung, Ross
Gupta, Sachin
Matthiesson, Kati
Tiruvoipati, Ravindranath
author_sort Banakh, Iouri
collection PubMed
description Sodium–glucose cotransporter 2 inhibitors (SGLT2Is) can be associated with euglycemic diabetic ketoacidosis (eDKA). Severe metabolic acidosis with extreme electrolyte abnormalities can occur with nonsignificant blood glucose elevations in SGLT2I‐treated patients. Additional risk factors for eDKA include prolonged fasting, major illness, large weight loss, and reductions in insulin doses.
format Online
Article
Text
id pubmed-6509932
institution National Center for Biotechnology Information
language English
publishDate 2019
publisher John Wiley and Sons Inc.
record_format MEDLINE/PubMed
spelling pubmed-65099322019-05-20 Euglycemic diabetic ketoacidosis in association with dapagliflozin use after gastric sleeve surgery in a patient with type II diabetes mellitus Banakh, Iouri Kung, Ross Gupta, Sachin Matthiesson, Kati Tiruvoipati, Ravindranath Clin Case Rep Case Reports Sodium–glucose cotransporter 2 inhibitors (SGLT2Is) can be associated with euglycemic diabetic ketoacidosis (eDKA). Severe metabolic acidosis with extreme electrolyte abnormalities can occur with nonsignificant blood glucose elevations in SGLT2I‐treated patients. Additional risk factors for eDKA include prolonged fasting, major illness, large weight loss, and reductions in insulin doses. John Wiley and Sons Inc. 2019-04-21 /pmc/articles/PMC6509932/ /pubmed/31110751 http://dx.doi.org/10.1002/ccr3.2147 Text en © 2019 The Authors. Clinical Case Reports published by John Wiley & Sons Ltd. This is an open access article under the terms of the http://creativecommons.org/licenses/by/4.0/ License, which permits use, distribution and reproduction in any medium, provided the original work is properly cited.
spellingShingle Case Reports
Banakh, Iouri
Kung, Ross
Gupta, Sachin
Matthiesson, Kati
Tiruvoipati, Ravindranath
Euglycemic diabetic ketoacidosis in association with dapagliflozin use after gastric sleeve surgery in a patient with type II diabetes mellitus
title Euglycemic diabetic ketoacidosis in association with dapagliflozin use after gastric sleeve surgery in a patient with type II diabetes mellitus
title_full Euglycemic diabetic ketoacidosis in association with dapagliflozin use after gastric sleeve surgery in a patient with type II diabetes mellitus
title_fullStr Euglycemic diabetic ketoacidosis in association with dapagliflozin use after gastric sleeve surgery in a patient with type II diabetes mellitus
title_full_unstemmed Euglycemic diabetic ketoacidosis in association with dapagliflozin use after gastric sleeve surgery in a patient with type II diabetes mellitus
title_short Euglycemic diabetic ketoacidosis in association with dapagliflozin use after gastric sleeve surgery in a patient with type II diabetes mellitus
title_sort euglycemic diabetic ketoacidosis in association with dapagliflozin use after gastric sleeve surgery in a patient with type ii diabetes mellitus
topic Case Reports
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6509932/
https://www.ncbi.nlm.nih.gov/pubmed/31110751
http://dx.doi.org/10.1002/ccr3.2147
work_keys_str_mv AT banakhiouri euglycemicdiabeticketoacidosisinassociationwithdapagliflozinuseaftergastricsleevesurgeryinapatientwithtypeiidiabetesmellitus
AT kungross euglycemicdiabeticketoacidosisinassociationwithdapagliflozinuseaftergastricsleevesurgeryinapatientwithtypeiidiabetesmellitus
AT guptasachin euglycemicdiabeticketoacidosisinassociationwithdapagliflozinuseaftergastricsleevesurgeryinapatientwithtypeiidiabetesmellitus
AT matthiessonkati euglycemicdiabeticketoacidosisinassociationwithdapagliflozinuseaftergastricsleevesurgeryinapatientwithtypeiidiabetesmellitus
AT tiruvoipatiravindranath euglycemicdiabeticketoacidosisinassociationwithdapagliflozinuseaftergastricsleevesurgeryinapatientwithtypeiidiabetesmellitus

Ejemplares similares